Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen

Inclusion Criteria: For all patients: * Patient aged ≤50 years, with WHO category II or III contacts happened within 48 hours before appearance at site. For adults: * Informed consent form has been signed and dated. * Able to attend all scheduled visits and to comply with all trial procedures. For children: * For children under 18 years of age, informed consent form has been signed and dated by the parent(s) or another legally acceptable representative. * For children under 18 years, assent form or informed consent form has been signed and dated by the appropriate age-range patient, according to country specific institution requirement as detailed in each country specific assent form or informed consent form. * Patient and parent/guardian are able to attend all scheduled visits and to comply with all trial procedures. Exclusion Criteria: For all patients: * Receipt of chloroquine or other medications used for malaria chemoprophylaxis, with or without other anti-malarial treatment, for more than 4 weeks (duration of anti-malarial course) and part of the treatment received within the 2 weeks before vaccination. * Participation in another clinical trial investigating a vaccine, drug, medical device, or medical procedure in the 4 weeks preceding the first trial immunization * Planned participation in another clinical trial during the present trial period * Receipt of any vaccine in the 4 weeks preceding the first trial vaccination, except for influenza vaccination and te…